84
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Role of new agents affecting NO/cGMP pathway on ovalbumin-sensitized guinea pig trachea

, , &
Pages 420-426 | Received 30 Mar 2012, Accepted 04 Aug 2012, Published online: 03 Oct 2012

REFERENCES

  • Feder LS, Stelts D, Chapman RW, Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol. 1997;17:436–442.
  • Trifilieff A, Fujitani Y, Mentz F, Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol. 2000;165:1526–1533.
  • Ferreira HHA, Bevilacqua E, Gagioti SM, Nitric oxide modulates the eosinophil infiltration in antigen-induced airway inflammation in rats. Eur J Pharmacol. 1998;358:253–259.
  • Mizutani N, Nabe T, Takenaka H, Acquired nasal hyper responsiveness aggravates antigen-induced rhinitis in the guinea pig. J Pharmacol Sci. 2003;93:437–445.
  • Alonso A, Rodriguez SR, Rodriguez SM, Interstitial pneumonitis induced in guinea pigs by the antigens of Rhizopus nigricans. J. Investig Allergol Clin Immunol. 1997;7:103–109.
  • Tulic MK, Wale JL, Holt PG, Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model. Eur Respir J. 2000;15:870–877.
  • Ricciardolo FL Sterk PJ, Gaston B, Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84:731–765.
  • Meurs H, Maarsingh H, Zaagsma J: Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyper responsiveness. Trends Pharmacol Sci. 2003;24:450–455.
  • Ricciardolo FL, Zaagsma J, Meurs H: The therapeutic potential of drugs targeting the arginase pathway in asthma. Expert Opin Investig Drugs. 2005;14:1221–1231.
  • Massaro AF, Mehta S, Lilly CM, Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996;153:1510–1514.
  • Dupont LJ, Rochette F, Demedts MG, Exhaled nitric oxide correlates with airway hyper responsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med. 1998;157:894–898.
  • Mulrennan SA, Redington AE: Nitric oxide synthase inhibition: therapeutic potential in asthma. Treat Respir Med. 2004;3(2):79–88.
  • Singh D, Richards D, Knowles RG, Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med. 2007;176:988–993.
  • Cevit O, Bagcivan I, Sarac B, Mechanism of relaxation induced by nicotine in normal and ovalbumin-sensitized guinea-pig trachea. Eur J Pharmacol. 2007;567:149–154.
  • Tallet D, Del Soldato P, Oudart N, NO-steroids: potent anti-inflammatory drugs with bronchodilating activity in vitro. Biochem Biophys Res Commun. 2001;290:125–130.
  • Broide DH, Lotz M, Cuomo AJ, Cytokines in symptomatic asthma airways. J Allergy Clin Immuno. 1992;89:958–967.
  • Jeffery PK, Wardlaw AJ, Nelson FC, Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 1989;140: 1745–1753.
  • Aikawa T, Shimura S, Sasaki H, Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 1992;101:916–921.
  • Nijkamp FP, Van Der Linde HJ, Folkerts G: Nitric oxide synthesis inhibitors induce airway hyper responsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am Rev Respir Dis. 1993;148:727–734.
  • Adelroth EAC, O'Byrne PM: Inflammatory mechanisms in airway hyper responsiveness. In: Busse WW, Holgate ST, Reed CE, eds. Asthma and Rhinitis. Vol. 2. Holgate, London: Blackwell Science; 2000:1273–1281.
  • Bredenbroker D, Dyarmand D, Meingast U, Effects of the nitric oxide-cGMP system compared with the cAMP system on airway mucus secretion in the rat. Eur J Pharm. 2001;411:319–325.
  • Maarsingh M, Leusink J, Zaagsma J, Role of the L-citrulline/L-arginine cycle in iNANC nerve-mediated nitric oxide production and airway smooth muscle relaxation in allergic asthma. Eur J Pharm. 2006;546:171–176.
  • Barnes PJ: Nitric oxide and airway disease. Ann Med. 1995;27:389–393.
  • Koarai A, Ichinose M, Sugiura H, Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400 W, in mice. Pulm Pharmacol Ther. 2000;13:267–275.
  • Fischer A, Mundel P, Mayer B, Nitric oxide synthase in guinea pig lower airway innervation. Neurosci Lett. 1993;149:157–160.
  • Maarsingh H, Leusink J, Bos IS, Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res. 2006;7:6.
  • Vaali K, Li L, Paakkari I, Relaxing effects of NO donors on guinea pig trachea in vitro are mediated by calcium-sensitive potassium channels. J Pharmacol Exp Ther. 1998;286(1):110–114.
  • Tuncel BI, Sadan G: Effects of phosphodiesterase V inhibition on nitric oxide-mediated relaxation responses in guinea pig trachea. Pharmacology. 2004;71(2):102–106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.